TIMOTHY J WAGNER
Allopathic & Osteopathic Physicians|Family Medicine AMHERST, OH NPI 1205949690
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine OH GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$9,007.82
- Category: General Payments
- Program years: PY2018–2024
- Record count: 648
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,345.09 across 83 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,345.09 | 83 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $169.81 | 17 |
| PFIZER INC. | $144.41 | 13 |
| Lilly USA, LLC | $135.80 | 10 |
| ABBVIE INC. | $103.15 | 5 |
| Corcept Therapeutics | $98.19 | 3 |
| Merck Sharp & Dohme Corporation | $72.77 | 4 |
| Astellas Pharma US Inc | $58.33 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $47.34 | 3 |
| Xeris Pharmaceuticals, Inc. | $45.47 | 2 |
| Amgen Inc. | $44.46 | 2 |
| Janssen Pharmaceuticals, Inc | $43.40 | 2 |
| Inspire Medical Systems, Inc. | $37.50 | 1 |
| Otsuka America Pharmaceutical, Inc. | $36.12 | 2 |
| Vanda Pharmaceuticals Inc. | $35.74 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.34 | 2 |
| Axsome Therapeutics, Inc. | $33.04 | 1 |
| Exact Sciences Corporation | $31.53 | 2 |
| Agile Therapeutics, Inc. | $21.40 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.07 | 1 |
| Acerta Pharma LLC | $18.45 | 1 |
| DEXCOM, INC. | $17.78 | 1 |
| Medtronic, Inc. | $16.49 | 1 |
| Novo Nordisk AS | $15.36 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $14.50 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.49 | 1 |
| Esperion Therapeutics, Inc. | $14.46 | 1 |
By program year
Records — PY2024 (83)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.